Aromics

Executive Summary

Aromics is a private Spanish biotechnology company based in Barcelona, founded in 2005. The company focuses on the discovery and development of novel drugs and diagnostic methods, leveraging OMIC technologies to gain biological insights and advance precision medicine. With a dual focus on diagnostics and small molecules, Aromics aims to improve patient quality of life through targeted therapies and companion diagnostics. However, specific pipeline assets, funding history, and clinical-stage programs are not publicly disclosed, making near-term visibility limited. The company operates in a competitive precision medicine landscape, and its long-standing presence suggests accumulated expertise, though lack of public milestones hinders assessment of current momentum.

Upcoming Catalysts (preview)

• Q4 2026Lead Program Milestone Announcement25% success